SOLVENTUM CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 63.74 USD | -1.68% |
|
-1.41% | 0.00% |
| May. 09 | Solventum Q1 Adjusted Earnings Decline, Net Sales Increase | MT |
| May. 09 | Earnings Flash (SOLV) SOLVENTUM Posts Q1 Revenue $2.02B | MT |
Valuation
| Fiscal Period: December | 2024 | 2025 | 2026 |
|---|---|---|---|
| Capitalization 1 | 11,008 | - | - |
| Enterprise Value (EV) 1 | 18,010 | 17,481 | 16,563 |
| P/E ratio | 16.7 x | 16 x | 12.5 x |
| Yield | - | - | - |
| Capitalization / Revenue | 1.36 x | 1.34 x | 1.32 x |
| EV / Revenue | 2.23 x | 2.14 x | 1.98 x |
| EV / EBITDA | 8.51 x | 8.11 x | 7.24 x |
| EV / FCF | 23.6 x | 19.6 x | 15.8 x |
| FCF Yield | 4.23% | 5.1% | 6.33% |
| Price to Book | 2.72 x | 2.44 x | 2.04 x |
| Nbr of stocks (in thousands) | 172,709 | - | - |
| Reference price 2 | 63.74 | 63.74 | 63.74 |
| Announcement Date | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Net sales 1 | - | 8,087 | 8,187 | 8,348 |
| EBITDA 1 | - | 2,117 | 2,157 | 2,289 |
| EBIT 1 | - | 1,765 | 1,655 | 1,690 |
| Operating Margin | - | 21.83% | 20.22% | 20.25% |
| Earnings before Tax (EBT) 1 | 1,667 | 917 | 1,008 | 1,105 |
| Net income 1 | 1,346 | 905 | 920.3 | 878 |
| Net margin | - | 11.19% | 11.24% | 10.52% |
| EPS 2 | - | 3.825 | 3.985 | 5.090 |
| Free Cash Flow 1 | - | 761.6 | 892.3 | 1,048 |
| FCF margin | - | 9.42% | 10.9% | 12.55% |
| FCF Conversion (EBITDA) | - | 35.98% | 41.37% | 45.79% |
| FCF Conversion (Net income) | - | 84.15% | 96.96% | 119.36% |
| Dividend per Share 2 | - | - | - | - |
| Announcement Date | 2/20/24 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|
| Net sales 1 | 2,016 | 2,046 | 2,004 | 1,999 | 2,020 |
| EBITDA 1 | 520 | 464.5 | 530 | 418.5 | 451.7 |
| EBIT 1 | 484 | 433.2 | 456.5 | 387.7 | 407.2 |
| Operating Margin | 24.01% | 21.17% | 22.78% | 19.4% | 20.16% |
| Earnings before Tax (EBT) | - | - | - | - | - |
| Net income | - | 231 | 287.6 | 203.4 | 235.4 |
| Net margin | - | 11.29% | 14.35% | 10.18% | 11.65% |
| EPS | - | 0.6300 | 0.9600 | 0.4700 | 0.8100 |
| Dividend per Share | - | - | - | - | - |
| Announcement Date | 5/9/24 | - | - | - | - |
1USD in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Net Debt 1 | - | 7,002 | 6,473 | 5,554 |
| Net Cash position 1 | - | - | - | - |
| Leverage (Debt/EBITDA) | - | 3.308 x | 3.001 x | 2.427 x |
| Free Cash Flow 1 | - | 762 | 892 | 1,048 |
| ROE (net income / shareholders' equity) | - | 38.2% | 23.3% | 23% |
| ROA (Net income/ Total Assets) | - | - | - | - |
| Assets 1 | - | - | - | - |
| Book Value Per Share 2 | - | 23.40 | 26.20 | 31.20 |
| Cash Flow per Share 2 | - | 6.910 | 6.750 | - |
| Capex 1 | - | 450 | 450 | 450 |
| Capex / Sales | - | 5.56% | 5.5% | 5.39% |
| Announcement Date | 2/20/24 | - | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
63.74
USD
Average target price
69.67
USD
Spread / Average Target
+9.30%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| 0.00% | 11.01B | |
| +20.68% | 85.55B | |
| -29.31% | 70.07B | |
| +9.65% | 29.06B | |
| -8.63% | 17.51B | |
| +2.14% | 17.39B | |
| +0.39% | 15.38B | |
| +6.47% | 13.4B | |
| +68.23% | 12.42B | |
| +6.43% | 12.77B |
- Stock Market
- Equities
- SOLV Stock
- Financials Solventum Corporation